XBiotech Inc.
NASDAQ:XBIT
3.89 (USD) • At close January 15, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 4.01 | 18.394 | 43.997 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 1.744 | 0.651 | 5.82 | 34.548 | 2.361 | 2.433 | 1.484 | 0.698 | 0.699 | 0 | 0 | 0 |
| Gross Profit
| -1.744 | 3.359 | 12.574 | 9.449 | -2.361 | -2.433 | -1.484 | -0.698 | -0.699 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0.838 | 0.684 | 0.215 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 32.848 | 31.544 | 28.268 | 9.527 | 24.09 | 15.725 | 26.424 | 42.486 | 31.31 | 14.329 | 7.935 | 13.334 |
| General & Administrative Expenses
| 4.662 | 6.305 | 9.388 | 18.198 | 7.143 | 5.269 | 7.635 | 10.277 | 6.2 | 7.449 | 1.99 | 1.829 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 4.662 | 6.305 | 9.388 | 18.198 | 7.143 | 5.269 | 7.635 | 10.277 | 6.2 | 7.449 | 1.99 | 1.829 |
| Other Expenses
| 0 | -0.121 | -0.132 | -0.503 | 750.01 | 0.004 | 0 | 0 | 0.021 | 0 | 0 | 0 |
| Operating Expenses
| 37.51 | 37.849 | 37.656 | 27.725 | 31.233 | 20.994 | 34.059 | 52.763 | 37.51 | 21.778 | 9.925 | 15.163 |
| Operating Income
| -37.51 | -34.49 | -25.082 | -18.276 | -31.233 | -20.994 | -34.059 | -52.763 | -37.51 | -21.778 | -9.925 | -15.163 |
| Operating Income Ratio
| 0 | -8.601 | -1.364 | -0.415 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 13.197 | 0.902 | -0.376 | 5.449 | 749.686 | -0.144 | 0.909 | 0.002 | 0.027 | 0.054 | -0.002 | 0.003 |
| Income Before Tax
| -24.313 | -33.588 | -25.458 | -12.827 | 718.453 | -21.138 | -33.15 | -52.761 | -37.483 | -21.724 | -9.927 | -15.16 |
| Income Before Tax Ratio
| 0 | -8.376 | -1.384 | -0.292 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.244 | -0.688 | -8.044 | -1.606 | 49.824 | -0.144 | -0.909 | -0.002 | -0.006 | -0.054 | 0.002 | 0 |
| Net Income
| -24.557 | -32.9 | -17.414 | -11.221 | 668.629 | -21.138 | -33.15 | -52.761 | -37.483 | -21.724 | -9.927 | -15.16 |
| Net Income Ratio
| 0 | -8.204 | -0.947 | -0.255 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.81 | -1.08 | -0.58 | -0.36 | 17.17 | -0.59 | -0.95 | -1.63 | -1.22 | -0.68 | -0.31 | -0.48 |
| EPS Diluted
| -0.81 | -1.08 | -0.58 | -0.36 | 14.44 | -0.59 | -0.95 | -1.63 | -1.22 | -0.68 | -0.31 | -0.48 |
| EBITDA
| -35.766 | -31.876 | -22.434 | -16.038 | -28.872 | -18.705 | -32.575 | -52.063 | -36.811 | -21.114 | -9.141 | -14.214 |
| EBITDA Ratio
| 0 | -7.251 | -1.181 | -0.444 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |